InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+0.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Bejar Rafael, Directeur Médical. Director active across 1 company, notably Aptose Biosciences Inc.. In total, 4 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €45k. History available since 19 November 2021. The latest transaction was disclosed on 19 January 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
244 sharesCommon SharesSEC:0000912282-26-000893:0
100,000 shares0Common SharesSEC:0001567619-23-001153:0
10,000 shares@ US$2.5650.0% of flowCommon SharesSEC:0001567619-21-020906
Ideal exit: 16 Aug 2022 (T+270)
10,000 shares@ US$2.560.57% mcap50.0% of flowCommon SharesSEC:0001567619-21-020906:0
Ideal exit: 16 Aug 2022 (T+270)
4 of 4 declarations
About Bejar Rafael
Rafael Bejar is the Chief Medical Officer at Aptose Biosciences Inc. He is responsible for the medical and scientific direction of the company, overseeing the development of new treatments and clinical research. His expertise in medicine and biotechnology is crucial for the innovation and success of the company. Rafael is committed to improving patient outcomes.
